We are thrilled to announce the establishment of miRoncol’s Business Advisory Board in April 2024. This group of experts is dedicated to providing strategic advice and guidance to advance our mission of revolutionizing cancer detection and democratizing access to early detection with accurate, affordable multi-cancer early blood tests.

Our board members include: